The phase II data are promising for patients who are managed with watchful waiting before being offered an intervention.
23hon MSN
Health Rounds newsletter excerpt has been corrected to indicate in the headline and the first item of the story that Sanofi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback